Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECRI Highlights Tech Hazards: Alarm Issues, Infusion Pumps Top Its 2014 List

This article was originally published in The Gray Sheet

Executive Summary

Alarm hazards, infusion pump medication errors and CT radiation exposures in pediatric patients lead ECRI Institute’s 2014 list of the top 10 health technology hazards. Risks from networked devices and robotic surgery also made the list.

You may also be interested in...



Gamma Camera Failures, Telemetry Shortcomings Added To ECRI's Top Tech Hazards

Gamma camera mechanical failures and surveillance challenges with telemetry-monitored patients monitored are two risks that have been elevated to the nonprofit ECRI Institute's Top 10 technology hazards for the first time in its 2016 listing, while inadequate cleaning of flexible endoscopes and missed alarms on monitoring equipment continue to be highlighted in the annual ranking.

Robot-Assisted Kidney Surgery Reduces Deaths, But Comparative Data Missing, Says Economist

Robot-assisted surgery for kidney cancers improves outcomes by allowing partial nephrectomies, reducing mortalities and lowering some health care costs said economist Julia Thornton Snider at a Feb. 5 biomedical innovation meeting, but researchers did not compare robotic surgeries with laparoscopic or open surgeries, nor did they examine costs of deaths or other bad patient outcomes linked to robotic surgeries.

FDA Hits Baxter With Two Warning Letters In Four Weeks

The warning letters cite quality system regulation violations related to the firm’s infusion pumps, including inadequate corrective and preventive actions related to complaints of over-infusion and device bladder ruptures.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032572

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel